Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Although we aim to reflect the most current medical knowledge, the material is meant for general education and awareness only
In the Phase 2b trial (2007, n=536) AOD-9604 showed weight reduction only 0.3 kg greater than placebo after 24 weeks
The patient frustration lies in feeling controlled by a law that treats a life-sustaining nutrient as if it were a high-risk pharmaceutical, simply because of how it is delivered
No, 5-Amino-1MQ isnt a direct fat burner in the sense of a thermogenic
Even Avecho Biotechnology (formerly Phosphagenics), a company who wanted to repurposed AOD-9604 as a transdermal formulation, knew why the clinical trials failed: AOD9604s delivery could have been the key issue
US$ 20.29
US$ 26.18
US$ 20.71
US$ 24.05
US$ 28.11
US$ 24.74
US$ 22.42
